Predictors and moderators of treatment response in childhood anxiety disorders: Results from the CAMS trial.
Journal of Consulting and Clinical Psychology2014Vol. 82(2), pp. 212–224
Citations Over TimeTop 1% of 2014 papers
Scott N. Compton, Tara S. Peris, Daniel Almirall, Boris Birmaher, Joel Sherrill, P C Kendall, John S. March, Elizabeth Gosch, Golda S. Ginsburg, Moira A. Rynn, John Piacentini, James T. McCracken, Courtney Keeton, Cynthia Suveg, Sasha G. Aschenbrand, Dara Sakolsky, Satish Iyengar, John T. Walkup, Anne Marie Albano
Abstract
Overall, anxious children responded favorably to CAMS treatments. However, having more severe and impairing anxiety, greater caregiver strain, and a principal diagnosis of social phobia were associated with less favorable outcomes. Clinical implications of these findings are discussed.
Related Papers
- → A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder(1997)92 cited
- → Placebo-Controlled, Multicenter Study of Sertraline Treatment for Obsessive-Compulsive Disorder(1999)81 cited
- → Clinical evaluation of the efficacy and safety of tandospirone versus sertraline monotherapy for social anxiety disorder: a randomized open‐label trial(2013)20 cited
- → Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study(2017)23 cited
- → Sertraline and IPT in dysthymia: One year follow-up(1998)2 cited